The Gerontologist
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lebowitz, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lebowitz, B. D.
The Gerontologist 44:452-458 (2004)
© 2004 The Gerontological Society of America

Clinical Trials in Late Life: New Science in Old Paradigms

Barry D. Lebowitz, PhD1,

Correspondence: Address correspondence to Barry D. Lebowitz, PhD, National Institute of Mental Health, 6001 Executive Blvd., Rm. 7160, MSC 9635, Bethesda, MD 20892. E-mail: blebowit{at}mail.nih.gov

This article, based on a Lawton Award Lecture, addresses the subject of the need to enhance the evidence base in our field in order to influence processes of policy development. Four issues are identified as critical to this: theory-driven targets of public health significance, use of appropriate and sophisticated approaches to research design and statistical modeling, development of instruments and measures, and conclusions that make a difference. Incentives are discussed with particular attention to regulatory approaches. A broad view of research is taken, with examples from studies of Alzheimer's disease and depression in late life. I conclude that new approaches to methodology will enhance our capacity to translate exciting new findings from the basic sciences into the development of therapeutics and that this will, in turn, enhance our capacity to inform the development of public policy.

Key Words: Clinical trials • Alzheimer's disease • Depression • Methodology




This article has been cited by other articles:


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
M. A. Espeland, T. M. Gill, J. Guralnik, M. E. Miller, R. Fielding, A. B. Newman, M. Pahor, and for the Lifestyle Interventions and Independence f
Designing Clinical Trials of Interventions for Mobility Disability: Results From the Lifestyle Interventions and Independence for Elders Pilot (LIFE-P) Trial
J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2007; 62(11): 1237 - 1243.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. Pinquart, P. R. Duberstein, and J. M. Lyness
Treatments for Later-Life Depressive Conditions: A Meta-Analytic Comparison of Pharmacotherapy and Psychotherapy
Am J Psychiatry, September 1, 2006; 163(9): 1493 - 1501.
[Abstract] [Full Text] [PDF]


Home page
GerontologistHome page
V. B. Mitrani, D. J. Feaster, B. E. McCabe, S. J. Czaja, and J. Szapocznik
Adapting the Structural Family Systems Rating to Assess the Patterns of Interaction in Families of Dementia Caregivers
Gerontologist, August 1, 2005; 45(4): 445 - 455.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All GSA journals Journals of Gerontology Series A: Biological Sciences and Medical Sciences Journals of Gerontology Series B: Psychological Sciences and Social Sciences
Copyright © 2004 by The Gerontological Society of America.